Page 7,187«..1020..7,1867,1877,1887,189..7,2007,210..»

Statement – Rx&D Applauds Government of Canada for Investing in Personalized Medicine

Posted: Published on February 2nd, 2012

OTTAWA , Feb. 1, 2012 /CNW/ - The following is a statement by Russell Williams , President of Canada's Research-Based Pharmaceutical Companies (Rx&D) on the announcement by the Government of Canada today to ensure that personalized medicine will allow for more effective treatments, thus supporting our Canadian health care system in a more sustainable way. "Canada's Research-Based Pharmaceutical Companies welcome this commitment by the Government of Canada to establish personalized medicine as the way to transform the delivery of health care to patients. "At Rx&D, we believe that providing the right medicine with the right dose to the right patient at the right time is crucial to improving health outcomes for Canadians. With the rise of chronic disease and an aging population, all governments are grappling with unprecedented demand for health care services. It is clear that we face a collective challenge to sustain and improve our health care system where traditional approaches are no longer efficient. "We commend the Government of Canada's commitment to engage in this work. Pharmaceutical innovation is a proven tool to help Canadians live longer, healthier, more productive lives. It is critical to the future productivity of our country, our workplaces, our communities and our … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Statement – Rx&D Applauds Government of Canada for Investing in Personalized Medicine

"For treatment we will have in the future" – Video

Posted: Published on February 2nd, 2012

20-01-2012 04:32 http://www.telethon.it - Pier Lorenzo Puri is a researcher at the Telethon Dulbecco Institute and works at the Santa Lucia Foundation in Rome. After a number of years as a researcher in the United States, he returned to Italy thanks to Telethon offering him a chance to create his own independent research laboratory in Italy in 2001.Having graduated as a medical doctor, Pier Lorenzo studies Duchenne muscular dystrophy and in particular the stage of the disease during which the patient's muscles try and mend themselves using particular stem cells. By intervening pharmacologically on this mechanism, Puri and his group aim to prolong for as long as possible this phase in which patients are still able to move autonomously and are above all more receptive to eventual treatment currently being studied. Read more: "For treatment we will have in the future" - Video … Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on "For treatment we will have in the future" – Video

Workshop 2: Fundamentals of Genetic Testing Part I – Selena Martinez – Video

Posted: Published on February 2nd, 2012

02-11-2011 12:51 Selena shares her family's experience with Lynch syndrome. This workshop is part of a genomics curriculum for practicing healthcare providers developed by the Genomic Medicine Institute at El Camino Hospital, Genetic Alliance, and the National Coalition for Health Professional Education in Genetics. This workshop, the second in a 10-part series, covered genetic-testing technology; selecting appropriate genetic tests; ordering tests; pre- and post-test counseling; test costs; interpreting test results. Read more: Workshop 2: Fundamentals of Genetic Testing Part I - Selena Martinez - Video … Continue reading →

Comments Off on Workshop 2: Fundamentals of Genetic Testing Part I – Selena Martinez – Video

Stem Cell Therapy in Neuromuscular Disease Research – Video

Posted: Published on February 2nd, 2012

31-01-2012 15:24 MDA Vice President of Research Sanjay Bidichandani explains the promising research being done in neuromuscular disease research using adult stem cells. Excerpt from: Stem Cell Therapy in Neuromuscular Disease Research - Video … Continue reading →

Comments Off on Stem Cell Therapy in Neuromuscular Disease Research – Video

New Frontiers in Basic Science – NEWS TIPS

Posted: Published on February 2nd, 2012

Embargoed for: 8 a.m. CT/9 a.m. ET, Wednesday, Feb. 1, 2012 NEW ORLEANS, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Regardless of presentation date and time, all four abstracts will have the same embargo release at 8 a.m. CT, Wednesday, Feb. 1, 2012. For more information Feb. 1-3, call the ASA News Media Staff Office at the New Orleans Convention Center at (504) 670-6010. Before or after these dates, call Communications in Dallas at (214) 706-1396. For public inquiries call (800) AHA-USA1 (242-8721). Abstract 3962 Animal study shows endothelial progenitor cells enhance motor function after stroke A new study found that rats, post-stroke, which were treated with endothelial progenitor cells had better functional outcomes than those left untreated. Endothelial progenitor cells (EPC) are produced in the bone marrow. They are "starter" cells for forming blood vessels. Higher levels of EPCs in the blood stream are associated with fewer heart attacks. In 34 male rats, researchers established baseline motor performance using a single pellet-reaching task. The animals were then divided into four groups: stroke alone, stroke plus EPC; sham plus EPC; and sham alone. Stroke was induced by delivering Endothelin-1 onto the middle cerebral artery contralateral to the preferred paw. One, three … Continue reading →

Posted in Pet Stem Cell Therapy | Comments Off on New Frontiers in Basic Science – NEWS TIPS

Circulating Tumor Cells – Expediting Clinical Use – Molecular Medicine Tri-Conference – Video

Posted: Published on February 2nd, 2012

01-02-2012 14:17 Visit our Website: http://www.triconference.com The rapid expansion in the use of circulating tumor cells (CTCs) as a diagnostic tool and a biomarker will provide a much needed tool in the treatment of cancer. The use of CTCs provides a non-invasive means of gaining early insight into tumor detection and metastasis, and has become an indispensable tool for patient management and oncology drug development. This conference dedicated to CTCs will cover a range of aspects concerning CTCs' origin, biology, characterization, enumeration and subsequent analysis. The conference will also highlight approaches to technology development that include the use of microfluidics for cell enumeration, and case studies on the clinical use of CTCs for guiding the selection of therapy and monitoring response. This meeting will bring you up to date on the state-of-the-art tools and what is needed to make these technologies robust and ready for use by the clinical community. Continue reading here: Circulating Tumor Cells - Expediting Clinical Use - Molecular Medicine Tri-Conference - Video … Continue reading →

Posted in Cell Medicine | Comments Off on Circulating Tumor Cells – Expediting Clinical Use – Molecular Medicine Tri-Conference – Video

Dr. Ramaswamy on Targeting Dormant Cancer Cells – Video

Posted: Published on February 2nd, 2012

01-02-2012 14:59 Sridhar Ramaswamy, MD, Massachusetts General Hospital Cancer Center, Assistant Professor of Medicine, Harvard Medical School, Harvard Stem Cell Institute, discusses targeting dormant cancer cells and the possible role that they play in the development of drug resistance. Dormant cells appear in most patients with tumors. These cells are not rapidly proliferating and remain largely inactive. While these cells sleep, they are highly resistant to most types of therapy. Dormant cancer cells are intrinsically intriguing because the number of inherent mutations would denote that the cells should be rapidly proliferating. The mechanism that allows them to switch between dormant and active is yet unknown. The goal of the research is to discover the underlying cause of the dormancy, tumor progression, and the mechanism of resistance to various types of therapy. Here is the original post: Dr. Ramaswamy on Targeting Dormant Cancer Cells - Video … Continue reading →

Posted in Cell Medicine | Comments Off on Dr. Ramaswamy on Targeting Dormant Cancer Cells – Video

Penicillin: The Greatest Chemical Discovery in the Past 100 Years – Video

Posted: Published on February 2nd, 2012

01-02-2012 15:01 Submitted for a competition for the Greatest Chemical Discovery in the Past 100 Years, this video explains the mechanism, chemistry, history and more about Penicillin. Read more: Penicillin: The Greatest Chemical Discovery in the Past 100 Years - Video … Continue reading →

Posted in Cell Medicine | Comments Off on Penicillin: The Greatest Chemical Discovery in the Past 100 Years – Video

New Drug Treats Fibroids With Fewer Side Effects

Posted: Published on February 2nd, 2012

Drug May Control Bleeding as Well as Older Drug Lupron, With Fewer Hot Flashes Feb. 1, 2012 -- A new drug appears to be effective for shrinking uterine fibroids and controlling the heavy menstrual bleeding they often cause, according to new research from Europe. In one study, the drug ulipristal acetate proved to be much more effective than a placebo for shrinking the non-malignant uterine tumors. In another, ulipristal acetate was found to be as effective as monthly injections of the drug Lupron for reducing heavy bleeding in women with uterine fibroids. Both studies appear in the Feb. 2 issue of The New England Journal of Medicine. Ulipristal acetate is the active chemical in the emergency contraceptive sold in the U.S. as Ella, but the daily doses taken by the fibroid patients in the studies were much smaller than those in the contraceptive. If trials now under way in the U.S. prove positive, New Jersey-based Watson Pharmaceuticals Inc. and Swiss-based PregLem hope to market ulipristal acetate as a fibroid treatment under the trade name Esmya, says Watson spokesman Charlie Mayr. 1 in 4 Women Have Fibroid Symptoms Uterine fibroids are the most common indication for the close to 600,000 hysterectomies … Continue reading →

Posted in Drug Side Effects | Comments Off on New Drug Treats Fibroids With Fewer Side Effects

Ssri Lexapro – Video

Posted: Published on February 2nd, 2012

09-01-2012 07:07 link to online store pillsrx24.com Ssri Lexapro Find patient medical information for Lexapro Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Lexapro (Escitalopram) 20mg I only had two real critiques, which is unusual for me.... See original here: Ssri Lexapro - Video … Continue reading →

Posted in Wholesale Pharmacy | Comments Off on Ssri Lexapro – Video

Page 7,187«..1020..7,1867,1877,1887,189..7,2007,210..»